Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Stock Quote Today & Recent News Pharming Group NV PHAR

Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company’s lead product is RUCONEST, a recombinant C1 esterase inhibitor for the treatment of acute attacks in adult and adolescent patients with acute hereditary angioedema... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >

Current News (NDAQ:PHAR)

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Pharming Group N.V. (PHAR) and Encourages Investors to Learn More About the Investigation

ACCESS Newswire 6 hours ago

Pharming Group N.V. (PHAR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

ACCESS Newswire 1 day ago

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pharming Group N.V. - PHAR

ACCESS Newswire 1 day ago

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pharming Group N.V. - PHAR

ACCESS Newswire 2 days ago

Pharming Group N.V. (PHAR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

ACCESS Newswire 2 days ago

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pharming Group N.V. - PHAR

ACCESS Newswire 2 days ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Pharming Group N.V. (PHAR) and Encourages Stockholders to Learn More About the Investigation

ACCESS Newswire 3 days ago

Bronstein, Gewirtz & Grossman, LLC Encourages Pharming Group N.V. (PHAR) Investors to Inquire about Securities Investigation

ACCESS Newswire 4 days ago

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pharming Group N.V. - PHAR

ACCESS Newswire 4 days ago

Opinion & Analysis (NDAQ:PHAR)

No current opinion is available.

Bullboard Posts (NDAQ:PHAR)

Buy Hydrocodone 10mg Online – Secure, Reliable, and Affordab

If you're looking to Buy Hydrocodone 10mg Online, Medix Discount is your trusted source for high-quality pain management solutions....
purdue786 - January 21, 2025

$IBGR: Premier Penny Stock with High Volume.

In the OTC market, $IBGR stands out brightly! With an impressive 30-day average volume of 934,610K shares, it emerges as the premier...
khandaanita4444 - February 9, 2024

$IBGR: A Stride into Innovation in the OTC Market

DRYWORLD Inc., traded as $IBGR on the OTC market, stands at the forefront of innovation, revolutionising the performance footwear...
christopher707 - February 9, 2024

$IBGR's Market Journey: A Tale of Resilience and Strength.

Take a deep dive into the market journey of $IBGR over the past 52 weeks, where its remarkable record is underscored by its expansive...
khandaanita4444 - February 8, 2024

Biggest opportunity of OTC here

This is going to multi dollars soon. Get in whilst its still cheap
EzyMilli - October 21, 2021